Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 13 | 129 | 83 | 546 | 660 |
| Gross Profit | 13 | 129 | 83 | 546 | 660 |
| Operating Expenses | 962 | 1,164 | 1,170 | 1,570 | 1,532 |
| Operating Income | -949 | -1,035 | -1,087 | -1,024 | -872 |
| Pre-tax Income | -949 | -1,035 | -1,087 | -1,024 | -872 |
| Net Income Continuous | -949 | -1,035 | -1,087 | -1,024 | -872 |
| Net Income | $-949 | $-1,035 | $-1,087 | $-1,024 | $-872 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | N/A | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | N/A | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-949 | $-1,035 | $-1,087 | $-1,012 | $-872 |